Search This Blog

Sunday, April 26, 2026

Adagio positive six‑month pivotal FULCRUM‑VT IDE trial results for vCLAS Ventricular Ablation System

 

Adagio Medical reports positive six‑month pivotal FULCRUM‑VT IDE trial results for vCLAS Ventricular Ablation System

  • Company plans to use FULCRUM‑VT vCLAS Ventricular Ablation System data to support an FDA Premarket Approval application.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)